Brief: Maia Biotechnology Reports Second Quarter 2022 Financial Results And Provides Corporate Update
22/08/2022 13:04
Aug 22 (Reuters) - Maia Biotechnology Inc MAIA.A :
* MAIA BIOTECHNOLOGY REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* MAIA BIOTECHNOLOGY INC - CURRENT CASH WITH PROCEEDS FROM
INITIAL
PUBLIC OFFERING IS ANTICIPATED TO BE SUFFICIENT TO FUND
OPERATIONS FOR NEXT 24 MONTHS
* MAIA BIOTECHNOLOGY INC - NET LOSS WAS APPROXIMATELY $3.3
MILLION
FOR QUARTER ENDED JUNE 30
Source text for Eikon: ID:nBw2bM5s6a
Further company coverage: MAIA.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maia Biotechnology
See all newsBrief: Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr In 3l Nsclc
Brief: Maia Biotechnology - To Terminate At The Market Offering Agreement Effective May 23, 2026 - SEC Filing
Brief: Maia Biotechnology Reports Overall Survival Exceeding Two Years For Eight Patients In Ongoing Phase 2 Clinical Trial In Non-Small Cell Lung Cancer
Brief: Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital Partners - SEC Filing
MAIA Biotechnology plunges after $30 million share sale